Peter H O'Donnell

19PUBLICATIONS
90CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyCancer geneticsPharmacogenomicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 23, 2025
Results of the ACCOuNT Trial: A Multi-Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients.

Zhong Huang, Kevin J O'Leary, Edith A Nutescu

|Jun 28, 2025
Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes.

Youngwoo Cho, Sami Elahi, Matthew M Jack

|Apr 08, 2025
Pharmacogenomics of chemotherapy induced peripheral neuropathy using an electronic health record-derived definition: a genome-wide association study.

Michael K Jones, Andrew Nicklawsky, Jonathan Shortt

|Mar 04, 2025
A National Study Among Diverse US Populations of Exposure to Prescription Medications with Evidence-Based Pharmacogenomic Information.

Loren Saulsberry, Jacob C Jameson, Robert D Gibbons

|Mar 27, 2024
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer.

Kunal B Desai, Anthony V Serritella, Walter M Stadler

|Jul 06, 2023
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations.

Deborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits

Pageof 4

Frequent Collaborators

3 joint publications

Mark J Ratain

3 joint publications

Matthew I Milowsky

2 joint publications

Walter M Stadler

2 joint publications

Kiang-Teck J Yeo